Anand Deshpande
Angel Investor
Pune, India
Anand Deshpande is a seed investor in Pune focused on Health Care and FinTech. Anand Deshpande is the Founder, Chairman, and Managing Director of Persistent Systems. Anand attended Indiana University Bloomington.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Anand Deshpande invests in
Stages Anand Deshpande invests in
Countries Anand Deshpande invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (50%)
- FinTech 1 (17%)
- Finance 1 (17%)
- Medical 1 (17%)
- Internet 1 (17%)
Stage
- Seed 2 (33%)
- Angel 1 (17%)
- Pre-Seed 1 (17%)
- Series A 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- India 4 (67%)
- United States 2 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Autonomous AI agents for Security Risk and Compliance | $18M / Series A / Sep 30, 2025 | ||
| GrowthPal is an M&A lead sourcing engine for corporates and high growth startups looking to acquire small to mid sized companies globally to add to their products, capabilities, teams, geographies and revenues. We use extensive technology, human Resources and our network to bring off the table "Ready to Transact" assets to the clientson the table and help them close deals at a much faster pace and a better transaction cost. We have provided our clients with more than 1500+ recommendations on assets, 120+ LOIs have been shared via our platform and 37 deals have been closed till now. | $1.4M / Venture - Series Unknown / May 27, 2024 | ||
| Serigen Mediproducts Private Limited is an unlisted private company incorporated on 03 February, 2015. It is classified as a private limited company and is located in Pune, Maharashtra. It's authorized share capital is INR 2.00 lac and the total paid-up capital is INR 1.52 lac. | $705.1K / Seed / Mar 29, 2023 | ||
| Blockfenders is a startup with a blockchain-powered platform that promises to help businesses share data more securely with one another. | $1.5M / Pre-Seed / Feb 07, 2023 | ||
| Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. | Seed / Apr 26, 2021 | ||
| Sushrut Designs conducts research to identify and design new healthcare products. Their product is the SitWalker FRX 100. They are revolutionary devices that blend with their surroundings and require no additional attention from the user. It increases blood circulation in the legs and reduces blood stagnation. | Angel / May 21, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Anand Deshpande invest in?
Anand Deshpande invests primarily in Health Care, FinTech and Finance startups, most often at Seed and Angel stage. Most of the 6 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Anand Deshpande?
Public channels for Anand Deshpande include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Anand Deshpande last invest?
The most recent investment recorded for Anand Deshpande closed in Sep 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
